Citations

Showing 10 of 108094 citations.

Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old
Lachner, Christian , Day, Gregory S. , Camsari, Gamze Balci, Ertekin‐Taner, Nilüfer , Labuzan, Sydney A. , Lucas, John A. , Thompson, E. Aubrey , Siddiqui, Habeeba, Cabrera‐Rodriguez, Janisse N, Josephs, Keith A. , Petersen, Ronald C. , Reichard, R. Ross , Graff‐Radford, Neill R. , Kouri, Naomi , Crook, Julia E. , Cabrera-Rodriguez, Janisse N, Day, Gregory S , Boeve, Bradley F. , Dickson, Dennis W. , Mielke, Michelle M. , Knopman, David S. , Murray, Melissa E.

Mayo Clinic

Journal of Alzheimer's Disease | October 4, 2022 | Volume: 90 | Issue: 1 | Pages: 405-417

10.3233/jad-220440 | PMID 36213996 Get It

Background: Dementia, vascular disease, and cancer increase with age, enabling complex comorbid interactions. Understanding vascular and cancer contributions to dementia risk and neuropathology in oldest-old may improve risk modification and outcomes. Objective: Investigate the contributions of vascular factors and cancer to dementia and neuropathology. Methods: Longitudinal clinicopathologic study of prospectively followed Mayo Clinic participants dying≥95 years-old who underwent autopsy. Participants were stratified by dementia status and compared according to demographics, vascular risk factors, cancer, and neuropathology. Results: Participants (n = 161; 83% female; 99% non-Hispanic whites)≥95 years (95–106 years-old) with/without dementia did not differ based on demographics. APOE ɛ2 frequency was higher in no dementia (20/72 [28%]) versus dementia (11/88 [12%]; p = 0.03), but APOE ɛ4 frequency did not differ. Coronary artery disease was more frequent in no dementia (31/72 [43%]) versus dementia (23/89 [26%]; p = 0.03) associated with 56% lower dementia odds (odds ratio [OR] = 0.44 [confidence interval (CI) = 0.19–0.98]; p = 0.04) and fewer neuritic/diffuse plaques. Diabetes had an 8-fold increase in dementia odds (OR = 8.42 [CI = 1.39–163]; p = 0.02). Diabetes associated with higher cerebrovascular disease (Dickson score; p = 0.05). Cancer associated with 63% lower dementia odds (OR = 0.37 [CI = 0.17–0.78]; p < 0.01) and lower Braak stage (p = 0.01). Conclusion: Cancer exposure in the oldest-old was associated with lower odds of dementia and tangle pathology, whereas history of coronary artery disease was associated with lower odds of dementia and amyloid-β plaque pathology. History of diabetes mellitus was associated with increased odds of dementia and cerebrovascular disease pathology. Cancer-related mechanisms and vascular risk factor reduction strategies may alter dementia risk and neuropathology in oldest-old.
Is There a Role for Prophylactic Antibiotics Post Pediatric Pyeloplasty?
Sheth, Kunj , Puttman, Kathleen, Nichols, Paige , King, Jordon , Zhu, Huirong, Ryan, Sheila L., Wang, Ming‐Hsien

Mayo Clinic

No container title available | October 4, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-23095/v2 Get It

Abstract Purpose: The use of postoperative prophylactic antibiotics in pediatric upper urinary tract reconstruction remains controversial. In this study, we elected to examine if low dose antibiotics (Abx) post pediatric dismember pyeloplasty reduce the incidence of urinary tract infections (UTIs) in our institution. As a secondary outcome, in patients who present with post op febrile UTIs, additional analysis was performed to better quantify which patient population benefits the most from low dose Abx. Methods: Institutional review board approval (IRB) was obtained. A retrospective study was performed in patients who underwent dismember pyeloplasty (2011-2017) at our institution. Patients with prior history of urologic interventions or other abnormalities of the genitourinary tract were excluded. Demographics (age, gender, ethnicity, insurance status), prior history of culture proven UTIs, surgical details (administration of perioperative antibiotics), and postoperative outcomes, including any readmission 30 days post repair, any urine samples, and culture results were collected. Results: 209 patients (149 boys, 60 girls) met our inclusion criteria. The average age was 6 years (range: 2 months-18 years). 160 patients (77%) underwent robotic-assisted pyeloplasty. Thirty-one patients underwent open repair (15%). 176 (84%) had an indwelling ureteral stent. Eleven patients (5%) had a culture-proven febrile UTI within 30-days postoperatively. No significant differences were seen in postoperative complications or incidence of UTIs when comparing surgical approaches, ureteral stent, or the use of prophylactic post-operative Abx. Secondary review of patients with post-operative febrile UTIs noted younger age (2.8 v. 6.2 years, p = 0.02) and positive intraoperative urine culture (p = 0.01) as significant risk factors. Conclusion: The incidence of postoperative UTIs in our cohort is relatively low. There is a higher incidence of febrile UTIs in patients less than 3 years old and those with positive intraoperative urine culture. The use of prophylactic Abx in patients post dismember pyeloplasty did not appear to affect the incidence of febrile culture proven UTIs, however, might be important in younger patients pre-potty training.
The Care of Women During Menopause
Files, Julia A. , Kransdorf, Lisa N , Kransdorf, Lisa N.

Mayo Clinic

Journal of Women's Health | October 4, 2022 | Volume: 31 | Issue: 10 | Pages: 1387-1390

10.1089/jwh.2022.0339 | PMID 36194084 Get It

Lactobacillus rhamnosus sepsis, endocarditis and septic emboli in a patient with ulcerative colitis taking probiotics
Karime, Christian , Barrios, Maria S. , Wiest, Nathaniel E. , Stancampiano, Fernando, Stancampiano, Fernando F.

Mayo Clinic

BMJ Case Reports | October 4, 2022 | Volume: 15 | Issue: 6 | Pages: e249020

10.1136/bcr-2022-249020 | PMID 35764338 Get It

A man in his 60s presented to the emergency room with fever and fatigue after a 2.5-month course of corticosteroids. His medical history was significant for bioprosthetic aortic valve replacement and moderately severe ulcerative colitis treated with balsalazide and daily lactobacillus-containing probiotics. Initial investigations revealed Lactobacillus rhamnosus bacteraemia without complication. Four days after hospital discharge, the patient experienced acute-onset right-sided paraesthesia and lower-limb paresis. On return to the emergency room, MRI of the brain demonstrated innumerable ring-enhancing lesions with haemorrhagic transformation. Transoesophageal echocardiogram revealed a small mobile density on the bioprosthetic aortic valve, raising the suspicion for L. rhamnosus infective endocarditis with secondary septic emboli to the brain. The patient was subsequently treated with intravenous gentamycin and ampicillin, with transition to indefinite oral amoxicillin suppressive therapy. The current case highlights the potential risk of lactobacilli translocation in an immunosuppressed patient with ulcerative colitis taking probiotics.
Hyperemesis Gravidarum and Nutritional Support
Elkins, Jaclyn R., Nguyen, Linda Anh B., Oxentenko, Amy S.

Mayo Clinic

American Journal of Gastroenterology | October 4, 2022 | Volume: 117 | Issue: 10S | Pages: 2-9

10.14309/ajg.0000000000001957 | PMID 36194027 Get It

Factors associated with successful weight loss after liraglutide treatment for obesity
Sannaa, Wassel , BouSaba, Joelle, Maselli, Daniel B. , Atieh, Jessica , Eckert, Deborah J., Taylor, Ann, Harmsen, William S. , Camilleri, Michael , Dilmaghani, Saam , Maselli, Daniel, Eckert, Deborah, Taylor, Ann L, Camilleri, M , Acosta, Andrés

Mayo Clinic

Diabetes, Obesity and Metabolism | October 4, 2022 | Volume: 25 | Issue: 2 | Pages: 377-386

10.1111/dom.14880 | PMID 36193713 Get It

Abstract Aim To identify patient factors, including gastrointestinal functions, that are predictive or associated with weight loss in response to once‐daily 3 mg liraglutide administered subcutaneously (SQ) or placebo in obesity. Methods One hundred and thirty‐six obese adults (87% female) were randomized in a placebo‐controlled, 16‐week trial of liraglutide, escalated to 3 mg administered SQ daily. Gastrointestinal functions were measured at baseline and 16 weeks: gastric emptying of solids (GET 1/2 ); fasting and postprandial gastric volumes; kcal ingested during ad libitum buffet meal and the nutrient drink test. GET 1/2 was also measured at 5 weeks. A multiple variable regression model examined variables associated with weight loss of more than 4 kg at 16 weeks. A parsimonious model using backward selection identified the final model. Results Weight loss of more than 4 kg at 16 weeks occurred in 71% of liraglutide‐ and 16% of placebo‐treated patients. In all participants combined, parameters univariately associated with a weight loss of more than 4 kg were GET 1/2 at 5 and 16 weeks, weight loss at 5 weeks and kcal intake during the buffet meal at 16 weeks. The final parsimonious model (area under the receiver operator characteristics [AUROC] curve = 0.832) identified that factors associated with more than 4‐kg weight loss were GET 1/2 at 5 weeks (OR = 2.505; 95% CI: 1.57‐3.997) per 50 minutes and kcal intake during ad libitum meal at 16 weeks (OR = 0.721; 95% CI: 0.602‐0.864) per 100 kcal. Among only the 60 liraglutide‐treated subjects, kcal intake at 16 weeks was associated with 4‐kg weight loss (AUROC = 0.757). Conclusions Slower GET 1/2 and weight loss at 5 weeks predicted a weight loss of more than 4 kg at 16 weeks in all participants. Among liraglutide‐treated adults, weight loss of more than 4 kg was associated with ad libitum meal kcal intake at 16 weeks.
Platelet-Derived Exosomes Induce Cell Proliferation and Wound Healing in Human Endometrial Cells
Miller, Colleen , Enninga, Elizabeth Ann L. , Rizzo, Skylar A. , Phillipps, Jordan , Guerrero‐Cazares, Hugo , DeStephano, Christopher C. , Peterson, Timothy E., Stalboerger, Paul G., Khan, Zaraq , Miller, Colleen M , L Enninga, Elizabeth Ann, Enninga, Elizabeth Ann L , Guerrero-Cazares, Hugo , Behfar, Atta

Mayo Clinic

Regenerative Medicine | October 4, 2022 | Volume: 17 | Issue: 11 | Pages: 805-817

10.2217/rme-2022-0095 | PMID 36193669 Get It

The Impact of Caprini Guideline Indicated Venous Thromboembolism Prophylaxis in Colorectal Surgery Patients: Experience of a Single Health System
Hyman, David W., Brennan, Emily , Spaulding, Aaron , Hussain, Md Walid Akram , Muraleedharan, Divya, Casler, John D., Schreier, Diana J., Thompson, Kristine M., Brennan, Emily R, Spaulding, Aaron C. , Colibaseanu, Dorin T, Akram Hussain, Md Walid, Schreier, Diana J , Edwards, Michael A. , Spaulding, Aaron , Colibaseanu, Dorin

Mayo Clinic

The American Surgeon™ | October 3, 2022 | Volume: 89 | Issue: 11 | Pages: 4720-4733

10.1177/00031348221129514 | PMID 36192381 Get It

Background Venous thromboembolism (VTE) is the most common cause of preventable mortality following colorectal surgery (CRS), occurring in about 2% of patients. As a result, prophylaxis including discharge chemoprophylaxis is recommended. While VTE risk assessment tools are available, the consistent adoption and utilization of these tools remains elusive. Our study objectives were to determine the utilization and impact of risk adjusted VTE prophylaxis in CRS patients. Study Design CRS cases performed between 1/1/2016 and 5/31/2021 were retrospectively analyzed. Caprini score and implemented VTE prophylaxis measures were determined. The primary outcome measure was receiving Caprini guideline indicated VTE prophylaxis. Secondary outcomes included VTE and bleeding. Categorical variables were compared by chi-square and Fisher’s exact tests, and continuous variables by Kruskal-Wallis test. Logistic regression models were used to determine predictors of receiving appropriate VTE prophylaxis or experiencing postoperative VTE and bleeding. Results 10,422 CRS cases were analyzed and 90.6% were high risk for VTE. In-hospital appropriate prophylaxis rates in low, moderate, high, and very high-risk category patients were 91.2%, 56.1%, 61.0%, and 63.1%, respectively. Inpatient VTE was reduced by 75% in those receiving appropriate VTE prophylaxis. At discharge, 5.8% of patients received appropriate prophylaxis, in whom there were no VTE events at 30- and 90 days from discharge. Increasing Caprini score positively correlated with VTE risk in both the inpatient and discharge cohorts, but inversely correlated with the likelihood of receiving appropriate prophylaxis at discharge (OR .31, P <.0001). Conclusion Caprini guideline indicated VTE prophylaxis in CRS patients reduced VTE events without increasing bleeding complications.
A Prospective Study of Lumbar Facet Arthroplasty in the Treatment of Degenerative Spondylolisthesis and Stenosis
Freedman, Brett A. , Sebastian, Arjun S. , Coric, Domagoj , Welch, William C. , Steinmetz, Michael P. , Robbins, Stephen E. , Ament, Jared D. , Anand, Neel , Baron, Eli M. , Whitmore, Robert G. , Whiting, Donald, Tahernia, David, Chahlavi, Ali, Chi, John, Pirris, Stephen M. , Groff, Michael W. , Fabi, Alain Y., Meyer, Scott A., Kushwaha, Vivek, Kent, Roland , DeLuca, Steven, Smorgick, Yossi , Anekstein, Yoram , Group, TOPS Study, Pinter, Zachariah W. , Nassr, Ahmad , Arnold, Paul M. , Huang, Jason Haitao , Sandhu, Faheem A. , Cheng, Joseph S. , Group, TOPS Study

Mayo Clinic

Clinical Spine Surgery | October 3, 2022 | Volume: 36 | Issue: 2 | Pages: E59-E69

10.1097/bsd.0000000000001365 | PMID 36191093 Get It

Study Design: Prospective randomized Food and Drug Administration investigational device exemption clinical trial. Objective: The purpose of the present study is to report the 1-year clinical and radiographic outcomes and safety profile of patients who underwent lumbar facet arthroplasty through implantation of the Total Posterior Spine System (TOPS) device. Summary of Background Data: Lumbar facet arthroplasty is one proposed method of dynamic stabilization to treat grade-1 spondylolisthesis with stenosis; however, there are currently no Food and Drug Administration-approved devices for facet arthroplasty. Methods: Standard demographic information was collected for each patient. Radiographic parameters and patient-reported outcome measures were assessed preoperatively and at regular postoperative intervals. Complication and reoperation data were also collected for each patient. Results: At the time of this study, 153 patients had undergone implantation of the TOPS device. The mean surgical time was 187.8 minutes and the mean estimated blood loss was 205.7cc. The mean length of hospital stay was 3.0 days. Mean Oswestry Disability Index, Visual Analog Score leg and back, and Zurich Claudication Questionnaire scores improved significantly at all postoperative time points (P>0.001). There were no clinically significant changes in radiographic parameters, and all operative segments remained mobile at 1-year follow-up. Postoperative complications occurred in 11 patients out of the 153 patients (7.2%) who underwent implantation of the TOPS device. Nine patients (5.9%) underwent a total of 13 reoperations, 1 (0.6%) of which was for device-related failure owing to bilateral L5 pedicle screw loosening. Conclusions: Lumbar facet arthroplasty with the TOPS device demonstrated a statistically significant improvement in all patient-reported outcome measures and the ability to maintain motion at the index level while limiting sagittal translation with a low complication rate.
Combined deconstructive and reconstructive treatment of a giant vertebrobasilar fenestration aneurysm
Rinaldo, Lorenzo , Oushy, Soliman , Oushy, Soliman H , Lanzino, Giuseppe

Mayo Clinic

Neurosurgical Focus: Video | October 3, 2022 | Volume: 7 | Issue: 2 | Pages: V7

10.3171/2022.7.focvid2256 | PMID 36425263 Get It

Aneurysms associated with a vertebrobasilar fenestration are rare lesions and can grow to a giant size, presenting significant therapeutic challenges. Endovascular treatment of these aneurysms has traditionally been with coiling; however, flow diverter placement within the fenestration arms has recently proven to be a viable treatment strategy. The authors present a case of a giant vertebrobasilar fenestration aneurysm in a patient presenting with a cranial nerve VI palsy. The lesion was treated by using a combination of flow diverter placement and vertebral artery sacrifice. The nuances of flow diversion therapy for these aneurysms and the management of intra- and postoperative complications are discussed. The video can be found here: https://stream.cadmore.media/r10.3171/2022.7.FOCVID2256